UMB Digital Archive > Graduate School > Theses and Dissertations Graduate School >

Please use this identifier to cite or link to this item: http://hdl.handle.net/10713/7072

Title: Discovery and Analysis of Patients with Monogenic Diabetes in Multiple Cohorts to Guide Future Diagnosis
Kleinberger_umaryland_0373D_10890.pdf  (3.78 MB)
Authors: Kleinberger, Jeffrey
Advisors: Pollin, Toni
Date: 2017
Embargoed Until: 2018-01-01
Abstract: Monogenic diabetes is hyperglycemia caused by a variant in a single gene, and it accounts for approximately 1-2% of all diabetes cases. A genetic diagnosis of monogenic diabetes is important because the most common gene etiologies can be effectively managed with treatment regimens other than first line treatments for either type 1 (T1D) or type 2 diabetes (T2D). However, monogenic diabetes can have a similar clinical presentation to either T1D or T2D, leading to clinical misdiagnosis of monogenic diabetes. The goal of this dissertation was to evaluate approaches for identifying patients with monogenic diabetes and a method for functionally testing monogenic diabetes variants to potentially improve diagnosis and treatment of these patients. Monogenic diabetes genetic testing was performed on 488 samples from the Treatment Options for type 2 Diabetes in Adolescents and Youth (TODAY) clinical trial. A total of 4.5% (22/488) of individuals were determined to have pathogenic or likely pathogenic variants. Comparison of clinical characteristics of patients with and without monogenic diabetes discovered statistically, but not clinically, significant lower BMI Z-score, higher fasting glucose, and lower fasting insulin in patients with monogenic diabetes. Treatment outcomes from the TODAY trial showed that most patients with HNF4A monogenic diabetes variants failed treatment therapies rapidly, while none of the patients with GCK monogenic diabetes variants failed treatment. In the Personalized Diabetes Medicine Program (PDMP), an implementation study for screening, diagnosis, and return of results for monogenic diabetes, 1,734 participants were screened for monogenic diabetes at four diverse study sites. Of the 138 eligible participants that underwent monogenic diabetes genetic testing, 14 had pathogenic or likely pathogenic monogenic diabetes variants. PDMP patients with monogenic diabetes had a diverse range of ages, races/ethnicities, and previous treatment regimens. Finally, a zebrafish model of hnf1a-knockdown and rescue with HNF1A monogenic diabetes variants was evaluated to determine that the model could not accurately identify established damaging HNF1A genetic variants. The results from these studies have demonstrated the variable presentations of patients with monogenic diabetes as well as the challenges and potential of assessing the function of HNF1A variants using an in vivo model.
Subject Keywords: clinical trial
MODY
monogenic diabetes
screening
Diabetes Mellitus, Type 2
Zebrafish
Description: University of Maryland, Baltimore. Molecular Medicine. Ph.D. 2017
Type: dissertation
Appears in Collections:Theses and Dissertations Graduate School
Theses and Dissertations School of Medicine

Items in UMB Digital Archive are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Contact Us | Terms and Conditions of Use | Privacy | Disclaimer

Copyright © 2011-2012 Health Sciences & Human Services Library. All Rights Reserved.